Profile - To The Moon

Desmondsg

Posts · 18Posts · 18
Following · 0Following · 0
Followers · 0Followers · 0

- DesmondsgDesmondsg
  ·12-19
  $YZJ Fin Hldg(YF8.SI)$
  1 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·11-13
  $Frasers Property(TQ5.SI)$
  40 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·10-08
  Great article, would you like to share it?
  @glimmero：
  $Micron Technology(MU)$ Micron (MU) is currently at bargain pricing. Consider the conservative forecast projecting increased sales and margin improvement over the next three years. Additionally, the company is building new U.S. fabs using its cash flow, which will generate substantial returns and dividends for the business in the future.
  $Micron Technology(MU)$ Micron (MU) is currently at bargain pricing. Consider the conservative forecast projecting increased sales and margin improvement over the next three years. Additionally, the company is building new U.S. fabs using its cash flow, which will generate substantial returns and dividends for the business in the future.
  162 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·10-08
  $Soilbuild Const(S7P.SI)$
  85 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·10-02
  Share your opinion about this news…
  Tesla Shares Tumble 5% After Missing Quarterly Delivery Estimates
  Tesla missed expectations for third-quarter deliveries on Wednesday, hurt by stiff competition from
  Tesla Shares Tumble 5% After Missing Quarterly Delivery Estimates
  97 Comment
  2
  Share
  Report
- DesmondsgDesmondsg
  ·07-12
  $SoundHound AI Inc(SOUN)$
  245 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·06-10
  Share your opinion about this news…
  Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds
  $Moderna, Inc.(MRNA)$'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company re
  Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds
  168 Comment
  2
  Share
  Report
- DesmondsgDesmondsg
  ·03-20
  $Ley Choon(Q0X.SI)$
  342 Comment
  Like
  Share
  Report
- DesmondsgDesmondsg
  ·03-12
  Share your opinion about this news…
  US February Core Inflation Data Slightly Hotter Than Expected
  US CPI YoY Actual 3.2% (Forecast 3.1%, Previous 3.1%)
  US February Core Inflation Data Slightly Hotter Than Expected
  209 Comment
  3
  Share
  Report
- DesmondsgDesmondsg
  ·02-13
  $PanUnited(P52.SI)$
  171 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3557888867112544","uuid":"3557888867112544","gmtCreate":1596628006302,"gmtModify":1596628006302,"name":"Desmondsg","pinyin":"desmondsg","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":18,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.04","exceedPercentage":"93.08%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":383287882809488,"gmtCreate":1734581151282,"gmtModify":1734581153736,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$&nbsp;</a>&nbsp;","text":"$YZJ Fin Hldg(YF8.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/383287882809488","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370576587198528,"gmtCreate":1731474792315,"gmtModify":1731474794776,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TQ5.SI\">$Frasers Property(TQ5.SI)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TQ5.SI\">$Frasers Property(TQ5.SI)$</a>&nbsp;","text":"$Frasers Property(TQ5.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/370576587198528","isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":357850823278920,"gmtCreate":1728402707523,"gmtModify":1728402709825,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357850823278920","repostId":"357707195965456","repostType":1,"repost":{"id":357707195965456,"gmtCreate":1728354040377,"gmtModify":1728354696226,"author":{"id":"9000000000000479","authorId":"9000000000000479","name":"glimmero","avatar":"https://static.tigerbbs.com/9e5f3c34ca3b3743623fe1884a908495","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000479","authorIdStr":"9000000000000479"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/MU\">$Micron Technology(MU)$</a> <v-v data-views=\"1\"></v-v>Micron (MU) is currently at bargain pricing. Consider the conservative forecast projecting increased sales and margin improvement over the next three years. Additionally, the company is building new U.S. fabs using its cash flow, which will generate substantial returns and dividends for the business in the future.","listText":"<a href=\"https://ttm.financial/S/MU\">$Micron Technology(MU)$</a> <v-v data-views=\"1\"></v-v>Micron (MU) is currently at bargain pricing. Consider the conservative forecast projecting increased sales and margin improvement over the next three years. Additionally, the company is building new U.S. fabs using its cash flow, which will generate substantial returns and dividends for the business in the future.","text":"$Micron Technology(MU)$ Micron (MU) is currently at bargain pricing. Consider the conservative forecast projecting increased sales and margin improvement over the next three years. Additionally, the company is building new U.S. fabs using its cash flow, which will generate substantial returns and dividends for the business in the future.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357707195965456","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":357769456349504,"gmtCreate":1728348143870,"gmtModify":1728348147022,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/S7P.SI\">$Soilbuild Const(S7P.SI)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/S7P.SI\">$Soilbuild Const(S7P.SI)$&nbsp;</a>&nbsp;","text":"$Soilbuild Const(S7P.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357769456349504","isVote":1,"tweetType":1,"viewCount":85,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355801415692528,"gmtCreate":1727875054699,"gmtModify":1727875058475,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355801415692528","repostId":"2472528662","repostType":2,"repost":{"id":"2472528662","kind":"live","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1727876854,"share":"https://ttm.financial/m/news/2472528662?lang=&edition=fundamental","pubTime":"2024-10-02 21:47","market":"us","language":"en","title":"Tesla Shares Tumble 5% After Missing Quarterly Delivery Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2472528662","media":"Reuters","summary":"Tesla missed expectations for third-quarter deliveries on Wednesday, hurt by stiff competition from ","content":"<html><head></head><body><p>Tesla missed expectations for third-quarter deliveries on Wednesday, hurt by stiff competition from rivals in China and Europe, sending shares of the world&#39;s most valuable automaker down 5% in morning trading.</p><p>The EV maker handed over 462,890 vehicles in the three months to Sept. 30, up 6.4% from the preceding quarter.</p><p>Wall Street on average had expected the Elon Musk-led company to deliver 469,828 vehicles, according to 12 analysts polled by LSEG.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/0e565b87428c808f9a1f05bd56a1ef62\" tg-width=\"783\" tg-height=\"622\"/></p><p style=\"text-align: start;\">The company has to deliver a record 516,344 vehicles in the fourth quarter to meet last year&#39;s delivery figure of 1.81 million units. A shortfall could result in Tesla recording its first annual drop in deliveries.</p><p>Rising competition in the United States, a lack of European subsidies and slowing consumer spending in China were a drag on Tesla&#39;s quarterly deliveries.</p><p>Tesla is contending with fierce competition from Chinese automakers like BYD and Xpeng, which are aggressively expanding their presence in the world&#39;s largest automotive market, with help from local government subsidies.</p><p>However, BYD&#39;s sales of 443,426 battery electric vehicles in the third quarter were lower than those of Tesla as the Chinese EV giant focused on plug-in hybrid vehicles, whose deliveries jumped more than 75% in the latest quarter.</p><p>In July, BMW led the European battery electric vehicle market for the first time, beating Tesla, which has been losing market share to domestic firms, according to a report by JATO Dynamics.</p><p>The price cuts and incentives have also squeezed Tesla&#39;s profit margins.</p><p>The company is expected to unveil its robotaxi product at a closely watched event on Oct. 10 in Los Angeles as it attempts a shift in strategy, with a focus on AI-powered autonomous technologies.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Shares Tumble 5% After Missing Quarterly Delivery Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Shares Tumble 5% After Missing Quarterly Delivery Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-10-02 21:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Tesla missed expectations for third-quarter deliveries on Wednesday, hurt by stiff competition from rivals in China and Europe, sending shares of the world&#39;s most valuable automaker down 5% in morning trading.</p><p>The EV maker handed over 462,890 vehicles in the three months to Sept. 30, up 6.4% from the preceding quarter.</p><p>Wall Street on average had expected the Elon Musk-led company to deliver 469,828 vehicles, according to 12 analysts polled by LSEG.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/0e565b87428c808f9a1f05bd56a1ef62\" tg-width=\"783\" tg-height=\"622\"/></p><p style=\"text-align: start;\">The company has to deliver a record 516,344 vehicles in the fourth quarter to meet last year&#39;s delivery figure of 1.81 million units. A shortfall could result in Tesla recording its first annual drop in deliveries.</p><p>Rising competition in the United States, a lack of European subsidies and slowing consumer spending in China were a drag on Tesla&#39;s quarterly deliveries.</p><p>Tesla is contending with fierce competition from Chinese automakers like BYD and Xpeng, which are aggressively expanding their presence in the world&#39;s largest automotive market, with help from local government subsidies.</p><p>However, BYD&#39;s sales of 443,426 battery electric vehicles in the third quarter were lower than those of Tesla as the Chinese EV giant focused on plug-in hybrid vehicles, whose deliveries jumped more than 75% in the latest quarter.</p><p>In July, BMW led the European battery electric vehicle market for the first time, beating Tesla, which has been losing market share to domestic firms, according to a report by JATO Dynamics.</p><p>The price cuts and incentives have also squeezed Tesla&#39;s profit margins.</p><p>The company is expected to unveil its robotaxi product at a closely watched event on Oct. 10 in Los Angeles as it attempts a shift in strategy, with a focus on AI-powered autonomous technologies.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","BK4592":"伊斯兰概念","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","BK4585":"ETF&股票定投概念","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","BK4555":"新能源车","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","LU0056508442.USD":"贝莱德世界科技基金A2","LU2063271972.USD":"富兰克林创新领域基金","LU0964807845.USD":"ALLIANZ INCOME & GROWTH \"A\" (USD) INC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","TSLA":"特斯拉","BK4527":"明星科技股","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","BK4588":"碎股","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","BK4550":"红杉资本持仓","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4574":"无人驾驶","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU1145028129.USD":"ALLIANZ INCOME AND GROWTH \"AQ\" (USD) INC","SG9999015978.USD":"利安颠覆性创新基金A","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4551":"寇图资本持仓","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","BK4581":"高盛持仓","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4511":"特斯拉概念","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4099":"汽车制造商","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241002:nFWN3LE176:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2472528662","content_text":"Tesla missed expectations for third-quarter deliveries on Wednesday, hurt by stiff competition from rivals in China and Europe, sending shares of the world's most valuable automaker down 5% in morning trading.The EV maker handed over 462,890 vehicles in the three months to Sept. 30, up 6.4% from the preceding quarter.Wall Street on average had expected the Elon Musk-led company to deliver 469,828 vehicles, according to 12 analysts polled by LSEG.The company has to deliver a record 516,344 vehicles in the fourth quarter to meet last year's delivery figure of 1.81 million units. A shortfall could result in Tesla recording its first annual drop in deliveries.Rising competition in the United States, a lack of European subsidies and slowing consumer spending in China were a drag on Tesla's quarterly deliveries.Tesla is contending with fierce competition from Chinese automakers like BYD and Xpeng, which are aggressively expanding their presence in the world's largest automotive market, with help from local government subsidies.However, BYD's sales of 443,426 battery electric vehicles in the third quarter were lower than those of Tesla as the Chinese EV giant focused on plug-in hybrid vehicles, whose deliveries jumped more than 75% in the latest quarter.In July, BMW led the European battery electric vehicle market for the first time, beating Tesla, which has been losing market share to domestic firms, according to a report by JATO Dynamics.The price cuts and incentives have also squeezed Tesla's profit margins.The company is expected to unveil its robotaxi product at a closely watched event on Oct. 10 in Los Angeles as it attempts a shift in strategy, with a focus on AI-powered autonomous technologies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":326722133528704,"gmtCreate":1720799510622,"gmtModify":1720799513422,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a>&nbsp;","text":"$SoundHound AI Inc(SOUN)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/326722133528704","isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315366116900928,"gmtCreate":1718025058016,"gmtModify":1718025061574,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/315366116900928","repostId":"2442810348","repostType":2,"repost":{"id":"2442810348","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1718032850,"share":"https://ttm.financial/m/news/2442810348?lang=&edition=fundamental","pubTime":"2024-06-10 23:20","market":"hk","language":"en","title":"Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds","url":"https://stock-news.laohu8.com/highlight/detail?id=2442810348","media":"Dow Jones","summary":"$Moderna, Inc.(MRNA)$'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company re","content":"<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&#39;s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna&#39;s Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> &#39;s Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>&#34;Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses,&#34; Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is &#34;just easier to administer - one shot and you&#39;re done,&#34; Moderna Chief Financial Officer Jamey Mock told MarketWatch. &#34;And hopefully it reduces the overall cost for them, because it should save time.&#34;</p><p>The trial results bode well for other combination shots in Moderna&#39;s pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. &#34;Clearly, we were able to do that,&#34; Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. &#34;We don&#39;t see that&#34; in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna&#39;s combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It&#39;s not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna&#39;s combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-06-10 23:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&#39;s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna&#39;s Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> &#39;s Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>&#34;Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses,&#34; Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is &#34;just easier to administer - one shot and you&#39;re done,&#34; Moderna Chief Financial Officer Jamey Mock told MarketWatch. &#34;And hopefully it reduces the overall cost for them, because it should save time.&#34;</p><p>The trial results bode well for other combination shots in Moderna&#39;s pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. &#34;Clearly, we were able to do that,&#34; Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. &#34;We don&#39;t see that&#34; in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna&#39;s combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It&#39;s not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna&#39;s combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","BK4535":"淡马锡持仓","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4501":"段永平概念","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","PFE":"辉瑞","SG9999002232.USD":"Allianz Global High Payout USD","BK4568":"美国抗疫概念","BK4588":"碎股","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4550":"红杉资本持仓","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4551":"寇图资本持仓","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4547":"WSB热门概念","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4581":"高盛持仓","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4548":"巴美列捷福持仓","MRNA":"Moderna, Inc.","SG9999001176.USD":"United Global Healthcare Acc USD","GSK":"葛兰素史克","LU1829250122.USD":"高盛欧洲核心股票组合Acc","BK4532":"文艺复兴科技持仓","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","BK4592":"伊斯兰概念","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","BNTX":"BioNTech SE","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2442810348","content_text":"Novavax drops 10% after Moderna, Inc.'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.The late-stage trial compared the investigational combo shot mRNA-1083 against the Sanofi SA flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against GlaxoSmithKline PLC 's Fluarix flu vaccine and Spikevax.In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.Pfizer and BioNTech SE are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and Novavax last month announced a deal that includes development of new flu and COVID combination vaccines.\"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses,\" Moderna CEO Stephane Bancel said in a statement.In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is \"just easier to administer - one shot and you're done,\" Moderna Chief Financial Officer Jamey Mock told MarketWatch. \"And hopefully it reduces the overall cost for them, because it should save time.\"The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. \"Clearly, we were able to do that,\" Mock said.The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. \"We don't see that\" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.","news_type":1},"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":286273579040928,"gmtCreate":1710925827030,"gmtModify":1710925830427,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a>&nbsp;","text":"$Ley Choon(Q0X.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/286273579040928","isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":283476442464392,"gmtCreate":1710246983863,"gmtModify":1710246997097,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/283476442464392","repostId":"1168053302","repostType":2,"repost":{"id":"1168053302","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710246644,"share":"https://ttm.financial/m/news/1168053302?lang=&edition=fundamental","pubTime":"2024-03-12 20:30","market":"us","language":"en","title":"US February Core Inflation Data Slightly Hotter Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=1168053302","media":"Tiger Newspress","summary":"US CPI YoY Actual 3.2% (Forecast 3.1%, Previous 3.1%)","content":"<html><head></head><body><p>Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.</p><p style=\"text-align: start;\">The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.</p><p style=\"text-align: start;\">Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5889035925b31691d094d1900524c4b4\" title=\"\" tg-width=\"914\" tg-height=\"105\"/></p><p style=\"text-align: start;\">While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.</p><p>A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.</p><p style=\"text-align: start;\">The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.</p><p style=\"text-align: start;\">Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US February Core Inflation Data Slightly Hotter Than Expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS February Core Inflation Data Slightly Hotter Than Expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2024-03-12 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.</p><p style=\"text-align: start;\">The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.</p><p style=\"text-align: start;\">Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5889035925b31691d094d1900524c4b4\" title=\"\" tg-width=\"914\" tg-height=\"105\"/></p><p style=\"text-align: start;\">While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.</p><p>A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.</p><p style=\"text-align: start;\">The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.</p><p style=\"text-align: start;\">Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168053302","content_text":"Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":273607305072704,"gmtCreate":1707836589600,"gmtModify":1707836594637,"author":{"id":"3557888867112544","authorId":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544","authorIdStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$&nbsp;</a>","text":"$PanUnited(P52.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/273607305072704","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}